drugset / Trial / NCT00123539

Estrogen Replacement to Reduce Risk of Neurologic Injury After Coronary Artery Bypass Graft Surgery

NCT00123539

RandomizedDouble-blindPrevention

Summary

The purpose of this study is to test whether perioperative estrogen replacement in postmenopausal women reduces the risk for neurologic injury after coronary artery bypass graft (CABG) surgery.

Timeline

Start
2001-06
Primary completion
Completion
2005-08

Drugs

EvaluationDrugModalityDoseRoute
Subject 17-beta estradiol Unknown